Recruiting NCT06851975
Research Into Biomarkers Predictive of Survival and Response to Cancer Treatment
For patients and families
In plain language
An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.
- What is being studied
- The protocol lists: blood sampling.
- Who it may be relevant to
- Registry conditions: Cancer. Basic parameters: from 18 years · All.
- What needs checking
- Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
- Where it takes place
- France
- Next step
- Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →
Unsure about the terms? Read our patient guide →
Overview
Research into biomarkers predictive of survival and response to cancer treatment
Interventions
- Other blood sampling
36ml of blood will be taken during a blood sampling performed in standard practice
Primary outcome measures
- Prediction [Time frame: day 1]
Eligibility criteria
Inclusion criteria
- Patient having a blood test, venous line insertion or injection on an implantable venous device scheduled as part of their standard care,
- Patient who has read the information note and stated that he/she has no objections
- Patient who has not objected to the use of this data for medical research purposes
- Patient with social security cover.
Exclusion criteria
- Patient already included in the study
- Patient considered to be a vulnerable person; vulnerable persons are defined in article L1121-5 to -8
Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.
Healthy volunteers: No
Study design
- Observational model
- Other
Study locations
France · 1 center
- Centre Antoine Lacassagne — Nice
Identifiers
NCT: NCT06851975 · 2018-61